No Aluminum, No Alzheimer’s Disease

Chris Exley, Professor in Bioinorganic Chemistry at Keele University, has recently published a new study that demonstrates that the classical senile plaques observed in the brain of people who died with Alzheimer’s disease (AD), are composed of both aluminum and amyloid-b.

“This is the second study confirming significantly high brain aluminum content in fAD but it is the first to demonstrate an unequivocal association between the location of aluminum and amyloid-β in fAD. It shows that two prominent risk factors in the etiology of AD.”

Titled “Aluminum and Amyloid-β in Familial Alzheimer’s Disease”, this latest finding adds to Exley’s ever growing body of research into the toxicity of Aluminum and its role in human disease including Alzheimer’s disease and Autism Spectrum Disorder.

Frustratingly, research into Al and its connection to AD dates back decades, yet has no mainstream appeal. It’s difficult to prove, and there’s no funding in going against a billion dollar industry. Despite decades of literally finding aluminum inside the plaques, in the neurofibrillary tangles–it’s still not formally recognized as a cause for AD. Instead, once again research proliferates at the notion of “genetic causes” rather than the very obvious environmental triggers.

Way back in 1965, researchers injected aluminum salts into the brains of rabbits (on a different hypothesis) and were astounded to find the adjuvant produced a severe convulsive state following latent period accompanied by striking neuronal changes throughout the central nervous system (CNS). Further investigation revealed that alum phosphate was responsible for this phenomenon and that the neuronal change consisted primary in a neurofibrillary degeneration.

Aluminum has no known biological function.”

“In 1975, the US Food and Drug Administration (FDA) granted “GRAS” status to nine different aluminum compounds, including aluminum hydroxide and aluminum phosphate, two aluminum adjuvants used as ingredients in current vaccines.

Demonstrably, the amount of aluminum in just one hepatitis B vaccine is over 14x the “safe limit” for how much a newborn would receive in one day.” (Think Love Healthy)

1965: “Experimental production of neurofibrillary degeneration. 1. Light microscopic observations

1978: “Aluminum levels in brain in Alzheimer’s disease.”

1995: “Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate.”

1995: “Accumulation of aluminium and silicon in lipofuscin granules.

2005: “Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients.”

2016: “The Identification of Aluminum in Human Brain Tissue Using Lumogallion and Fluorescence Microscopy